California Institute for Regenerative Medicine
Corporate investor
Active
San Francisco, United States
39
8M
35
2.05
18
0.10
10
- Areas of investment
Summary
In 2005 was created California Institute for Regenerative Medicine, which is appeared as Corporate Investor. The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the San Francisco.
Opposing the other organizations, this California Institute for Regenerative Medicine works on 35 percentage points more the average amount of lead investments. Considering the real fund results, this Corporate Investor is 71 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2017. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2013.
The overall number of key employees were 3.
Among the various public portfolio startups of the fund, we may underline Orchard Therapeutics, VistaGen Therapeutics, Sangamo Therapeutics Besides, a startup needs to be aged 11-15 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Clinical Trials, Medical Device. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 3 or 4 of the founder, the chance for it to be financed is low.
The usual cause for the fund is to invest in rounds with 1 partaker. Despite the California Institute for Regenerative Medicine, startups are often financed by Sanderling Ventures, Malin Corporation, Johnson & Johnson Development Corporation. In the next rounds fund is usually obtained by W.L. Gore & Associates, Vivo Capital, Temasek Holdings.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 39
- Lead investments
- 18
- Exits
- 10
- Rounds per year
- 2.05
- Follow on index
- 0.10
- Investments by industry
- Biotechnology (33)
- Health Care (22)
- Therapeutics (15)
- Medical (11)
- Pharmaceutical (5) Show 18 more
- Investments by region
-
- United States (36)
- United Kingdom (1)
- Israel (1)
- Peak activity year
- 2023
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Avg. valuation at time of investment
- 46M
- Avg. company exit year
- 6
- Avg. multiplicator
- 2.15
- Strategy success index
- 0.90
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.